Day One Biopharmaceuticals (DAWN) Stock Chart & Stock Price History $7.24 +0.30 (+4.25%) As of 01:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Day One Biopharmaceuticals Stock Price Performance The Day One Biopharmaceuticals (DAWN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 52.99%, with a year-to-date return of -42.90%. In the past month, the stock has increased 11.65%, reflecting recent market activity. As of the latest close, Day One Biopharmaceuticals traded at $6.94 with a market cap of $703.45 million and volume of 1.53 million shares. Receive DAWN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+13.05%1 Month Performance+11.65%3 Month Performance-8.42%Year-To-Date Performance-42.90%1 Year Performance-52.99% DAWN Stock Chart for Thursday, July, 24, 2025 DAWN Chart by TradingView Day One Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/23/2025$6.57$6.94+5.63%$6.99$6.581.53 million shs$703.45 million07/22/2025$6.40$6.57+2.66%$6.64$6.42894,498 shs$665.94 million07/21/2025$6.40$6.40$6.57$6.381.04 million shs$648.70 million07/18/2025$6.50$6.40-1.54%$6.62$6.321.87 million shs$648.70 million07/17/2025$6.62$6.50-1.81%$6.71$6.481.60 million shs$658.85 million07/16/2025$6.57$6.62+0.76%$6.73$6.521.55 million shs$671.00 million07/15/2025$6.93$6.57-5.19%$7.00$6.571.69 million shs$665.95 million07/14/2025$6.79$6.93+2.06%$7.00$6.69946,138 shs$702.44 million07/11/2025$7.19$6.79-5.56%$7.13$6.781.15 million shs$688.23 million07/10/2025$7.00$7.19+2.71%$7.24$6.881.61 million shs$728.78 million Get the Latest News and Ratings for DAWN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/09/2025$6.61$7.00+5.90%$7.05$6.631.41 million shs$709.52 million07/08/2025$6.63$6.61-0.30%$6.75$6.57822,839 shs$669.99 million07/07/2025$6.80$6.63-2.50%$6.81$6.521.14 million shs$672.03 million07/04/2025$6.80$6.80$6.86$6.75445,456 shs$689.26 million07/03/2025$6.73$6.80+1.04%$6.86$6.75445,456 shs$689.25 million07/02/2025$6.61$6.73+1.82%$6.95$6.561.46 million shs$682.15 million07/01/2025$6.50$6.61+1.69%$6.73$6.451.42 million shs$669.99 million06/30/2025$6.47$6.50+0.46%$6.56$6.361.40 million shs$658.84 million06/27/2025$6.48$6.47-0.15%$6.52$6.354.32 million shs$655.80 million06/26/2025$6.44$6.48+0.62%$6.50$6.351.11 million shs$656.81 million06/25/2025$6.48$6.44-0.62%$6.50$6.22660,325 shs$652.77 million06/24/2025$6.48$6.48$6.60$6.401.09 million shs$656.81 million06/23/2025$6.32$6.48+2.53%$6.54$6.201.36 million shs$656.81 million Related Companies Mirum Pharmaceuticals Stock Chart Catalyst Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart Amneal Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Ultragenyx Pharmaceutical Stock Chart Organon & Co. Stock Chart Apellis Pharmaceuticals Stock Chart ImmunityBio Stock Chart Xenon Pharmaceuticals Stock Chart Receive DAWN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DAWN) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
